How did Novo Nordisk A/S's revenue change from 2022 to 2023?

Novo Nordisk A/S revenue grew from $24.8B in 2022 to $33.4B in 2023, a change of 34.7%.

Was 2023 Novo Nordisk A/S's best revenue year?

No. Novo Nordisk A/S's highest recorded revenue year was 2024 at $42.7B. In 2023, Novo Nordisk A/S reported $33.4B.

What was Novo Nordisk A/S's highest ever annual revenue?

Novo Nordisk A/S's highest ever annual revenue was $42.7B recorded in fiscal year 2024.

Novo Nordisk A/S

PharmaceuticalsFounded 1989

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Explore Novo Nordisk A/S

Core profile pages, annual revenue records, and related research hubs for this company.

Novo Nordisk A/S

PharmaceuticalsFounded 1989

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Annual Revenue

Novo Nordisk A/S Revenue in 2023

Q: What was Novo Nordisk A/S's revenue in 2023?

Novo Nordisk A/S reported $33.4B in revenue for fiscal year 2023. This represents a +34.7% change compared to 2022. Revenue accelerated 34.7% to $33.4 billion in FY2023 as surging demand for the semaglutide drugs Ozempic and Wegovy reshaped the diabetes and obesity markets.

FY2023 Revenue

$33.4B

▲ 34.7% vs FY2022 ($24.8B)

Source: Annual report / company filing

Novo Nordisk A/S reported $33.4B in revenue for fiscal year 2023. This represents a growth of 34.7% compared to the 2022 figure of $24.8B. In 2024, revenue increased to $42.7B.

Revenue accelerated 34.7% to $33.4 billion in FY2023 as surging demand for the semaglutide drugs Ozempic and Wegovy reshaped the diabetes and obesity markets.

Revenue by Year

FY2024 FY2023 FY2022

Novo Nordisk A/S Annual Revenue History

Year	Revenue	Net Income	YoY Change
FY2024	$42.7B	$14.3B	+27.8%
FY2023	$33.4B	—	+34.7%
FY2022	$24.8B	—	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2022: $24.8B

Next year →

FY2024: $42.7B

Explore Novo Nordisk A/S

Core profile pages, annual revenue records, and related research hubs for this company.